Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.565B
March 31, 2026 1.574B
December 31, 2025 63.25M
September 30, 2025 64.97M
June 30, 2025 66.22M
March 31, 2025 67.81M
December 31, 2024 69.37M
September 30, 2024 359.85M
June 30, 2024 361.99M
March 31, 2024 364.20M
December 31, 2023 366.44M
September 30, 2023 369.92M
June 30, 2023 374.34M
March 31, 2023 378.75M
December 31, 2022 369.56M
September 30, 2022 389.64M
June 30, 2022 394.37M
March 31, 2022 399.18M
December 31, 2021 399.97M
September 30, 2021 404.30M
June 30, 2021 408.73M
March 31, 2021 413.21M
December 31, 2020 394.42M
September 30, 2020 372.22M
June 30, 2020 375.49M
Date Value
March 31, 2020 377.60M
December 31, 2019 282.48M
September 30, 2019 284.34M
June 30, 2019 287.09M
March 31, 2019 289.79M
December 31, 2018 279.31M
September 30, 2018 279.85M
June 30, 2018 280.39M
March 31, 2018 280.93M
December 31, 2017 281.44M
September 30, 2017 281.99M
June 30, 2017 282.55M
March 31, 2017 283.11M
December 31, 2016 283.67M
September 30, 2016 285.58M
June 30, 2016 347.03M
March 31, 2016 348.49M
December 31, 2015 349.94M
September 30, 2015 353.22M
June 30, 2015 354.81M
March 31, 2015 356.39M
December 31, 2014 357.97M
September 30, 2014 359.55M
June 30, 2014 361.13M
March 31, 2014 362.71M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 5.255M
Jazz Pharmaceuticals Plc 4.395B
Prothena Corp. Plc 4.03M
ACADIA Pharmaceuticals, Inc. 59.55M
Biogen, Inc. 8.355B